Skip to main content
Home / The International Journal of Tuberculosis and Lung Disease, Volume 28, Number 11

Free Content Building social equity and person-centred innovation into the end TB response

Download Article:
Reducing systemic inequities in testing, access to care, social protection – and in the scientific process – is essential to end TB. Incorporating social science methods and expertise on inequity into the mainstream TB response would help ensure that political commitments to equity move beyond symbolic gestures. We convened a meeting between TB social scientists, people with lived experience, civil society and community members to discuss equity within the global TB response. Here, we propose five means by which a social science lens can strengthen equitable, person-centred responses and reconcile the public health significance of TB with the principles of social justice.

Keywords: call to action; health equity; research agenda; social sciences; tuberculosis

Document Type: Editorial

Affiliations: 1: Maastricht University, Maastricht, The Netherlands;, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; 2: South Africa Department of Health, Cape Town, South Africa; 3: Yenepoya Medical College, Mangalore, India; 4: Sangath, Bhopal, India; 5: Center for Health Policies and Studies (PAS Center), Chiinău, Moldova; 6: York University, Toronto, Canada; 7: Human Sciences Research Council, Durban, South Africa; 8: University of Namibia, Windhoek, Namibia; 9: University of Geneva, Geneva, Switzerland; 10: Victorian Tuberculosis Program, Melbourne, Australia; 11: Treatment Action Group, New York, USA; 12: Harvard Medical School, Boston, USA; 13: University of Sydney, Sydney, Australia;, Stellenbosch University, Stellenbosch, South Africa;, University of Namibia, Windhoek, Namibia; 14: Université Paris Cité (Sorbonne), Paris, France; 15: Institute of Tropical Medicine, Antwerp, Belgium;, Queen Margaret University, Edinburgh, UK; 16: We Are TB, Madison, USA; 17: Burnet Institute, Melbourne, Australia; 18: Tulane University, New Orleans, USA; 19: Institute of Tropical Medicine, Antwerp, Belgium; 20: University of Waterloo, Waterloo, Canada; 21: McMaster University, Hamilton, Canada; 22: Network of TB Champions, Kenya;, Pamoja TB Group, Kenya; 23: Maastricht University, Maastricht, The Netherlands; 24: Wayne State University, Detroit, USA; 25: TB Proof, Cape Town, South Africa;, Oxford University, Oxford, UK; 26: Liverpool School of Tropical Medicine, Liverpool, UK;, Karolinska Institute, Stockholm, Sweden;, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK; 27: University of Ottawa, Ottawa, Canada; 28: York University, Toronto, Canada;, Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.

Publication date: November 1, 2024

More about this publication?

  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content